I tell you why I'm worried, if RES get's sold down to like 3 or 4c then it's going to take the return of the almighty to lift the sp again above the single digits.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
